| Literature DB >> 29183729 |
Szu-Mam Liu1, Chen-Huan Lin1, Jean Lu2, In-Yu Lin1, Mu-Shiun Tsai3, Ming-Hong Chen4, Nianhan Ma5.
Abstract
Tumors grow because cancer cells lack the ability to balance cell survival and death signaling pathways. miR-596, a microRNA located at the 8p23.3 locus, has been shown by the TCGA-Assembler to be deleted in a significant number of melanoma samples. Here, we also validated the low levels of miR-596 in melanoma compared to tissue nevi, and Kaplan-Meier curve analysis revealed that low miR-596 expression was associated with worse overall survival. Moreover, we showed that miR-596 overexpression effectively inhibited MAPK/ERK signaling, cell proliferation, migration, and invasion and increased the cell apoptosis of melanoma cells. In addition, we found that miR-596 directly targets MEK1 and two apoptotic proteins, MCL1, and BCL2L1, in melanoma cells. Our findings indicated that miR-596 is an important miRNA that both negatively regulates the MAPK/ERK signaling pathway by targeting MEK1 and modulates the apoptosis pathway by targeting MCL1 and BCL2L1, suggesting that miR-596 could be a therapeutic candidate for treating melanoma, and a prognostic factor for melanoma patients.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29183729 DOI: 10.1016/j.jid.2017.11.016
Source DB: PubMed Journal: J Invest Dermatol ISSN: 0022-202X Impact factor: 8.551